Viewing StudyNCT00546624



Ignite Creation Date: 2024-05-05 @ 6:46 PM
Last Modification Date: 2024-10-26 @ 9:37 AM
Study NCT ID: NCT00546624
Status: COMPLETED
Last Update Posted: 2015-11-01
First Post: 2007-10-17

Brief Title: GEM 15 mg bid to 45 mg bid Versus Lorazepam in GAD 0777-026
Sponsor: Merck Sharp Dohme LLC
Organization: Merck Sharp Dohme LLC

Key Dates - Follows AllAPIJSON File Order

Start Date: 2002-11
Start Date Type: None
Primary Completion Date: 2003-02
Primary Completion Date Type: ACTUAL
Completion Date: 2003-02
Completion Date Type: ACTUAL
First Submit Date: 2007-10-17
First Submit QC Date: October 17 2007
Study First Post Date: 2007-10-19
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2015-10-30
Last Update Post Date: 2015-11-01
Last Update Post Date Type: ESTIMATED